SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

75,719.72 -413.09
( -0.54%)

Global Indices

Nasdaq

53,435.25 -271.85
(-0.51%)

Dow Jones

7,739.60 -29.11
(-0.37%)

Hang Seng

66,225.50 1,204.56
(1.85%)

Nikkei 225

10,817.95 -13.14
(-0.12%)

Forex

USD-INR

94.44 -0.05
(-0.05%)

EUR-INR

109.67 -0.05
(-0.04%)

GBP-INR

127.62 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

IBL Finance Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

91871

INE0O7401018

24.7047085

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IBLFL

61.52

150.61

EPS(TTM)

Face Value()

Div & Yield %

0.99

Back

Shilpa Medicare appoints Dr. Uday N. Harle as CEO of Shilpa Biologicals

Aug 03,2026

Shilpa Medicare announced that Dr. Uday N. Harle has been appointed as the Chief Executive Officer (CEO) - Shilpa Biologicals, a wholly owned subsidiary of Shilpa Medicare (Senior Managerial Personnel) of the Company with effect from 03 August 2026.

75,719.72 -413.09 ( -0.54%)

53,435.25 -271.85 (-0.51%)

7,739.60 -29.11 (-0.37%)

66,225.50 1,204.56 (1.85%)

10,817.95 -13.14 (-0.12%)

94.44 -0.05 (-0.05%)

109.67 -0.05 (-0.04%)

127.62 -0.01 (-0.01%)

0.60 0.00 (0.12%)